Cardiovascular Effects of Berberine: A Review of the Literature
- Ayurveda Interdisciplinary Research Minds Association, Mysore, India
- Department of Basic Principles, S. V Ayurvedic Medical College, Tirupathi, Andhra Pradesh, India
*Corresponding author: Executive Secretary and Researcher, Ayurveda Interdisciplinary Research Minds Association, #1179, 19th Main, 2nd stage, JP Nagar, Mysore 570008, Karnataka, India, Tel.: +91-99162-86955; E-mail: doctor.arvi@gmail.com
DOI: https://doi.org/10.14200/jrm.2017.6.0100
©2017, Aravind Bagade, MD
ABSTRACT
INTRODUCTION
CHEMICAL CHARACTERISTICS AND PHARMACOKINETICS
VASCULAR ENDOTHELIUM AND THE HEART
BLOOD PRESSURE
GLUCOSE REGULATION
BLOOD LIPIDS
CONGESTIVE HEART FAILURE
INTERACTIONS, ADVERSE EFFECTS, AND SAFETY ISSUES
CONCLUSION
The authors wish to thank Elizabeth Sutherland, ND for her invaluable contribution to the development of this paper.
- Kamath S, Skeels M, Pai A. Significant differences in alkaloid content of Coptis chinensis (Huanglian), from its related American species.
- Gan RY. Bioactivities of berberine: an update.
- Kumar A, Ekavali, Chopra K, et al. Current knowledge and pharmacological profile of berberine: an update.
- Meneton P, Jeunemaitre X, de Wardener HE, MacGregor GA. Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases.
- Xia LM, Luo MH. Study progress of berberine for treating cardiovascular disease.
- Pan GY, Wang GJ, Liu XD, et al. The involvement of p-glycoprotein in berberine absorption.
- Feng R, Shou JW, Zhao ZX, et al. Transforming berberine into its intestine-absorbable form by the gut microbiota.
- Endemann DH, Schiffrin EL. Endothelial dysfunction.
- Rask-Madsen C, King GL. Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes.
- Affuso F, MercurioV, Fazio V, Fazio S. Cardiovascular and metabolic effects of berberine.
- Zhang Y, Lee TS, Kolb EM, et al. AMP-activated protein kinase is involved in endothelial NO synthase activation in response to shear stress.
- Dagher Z, Ruderman N, Tornheim K, Ido Y. The effect of AMP-activated protein kinase and its activator AICAR on the metabolism of human umbilical vein endothelial cells.
- Ido Y, Carling D, Ruderman N. Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation.
- Nagata D, Mogi M, Walsh K. AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress.
- Ouchi N, Shibata R, Walsh K. AMP-activated protein kinase signaling stimulates VEGF expression and angiogenesis in skeletal muscle.
- Hui KK, Yu JL, Chan WF, et al. Interaction of berberine with human platelet alpha 2 adrenoceptors.
- Henry PD, Cabello OA, Chen CH. Hypercholesterolemia and endothelial dysfunction.
- Montagnani M, Ravichandran LV, Chen H, et al. Insulin receptor substrate-1 and phosphoinositide-dependent kinase-1 are required for insulin-stimulated production of nitric oxide in endothelial cells.
- Affuso F, Ruvolo A, Micillo F, et al. Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study.
- Wang Y, Huang Y, Lam KS, et al. Berberine prevents hyperglycemia induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase.
- Zhang LS. Clinical usage of berberine.
- Ko WH, Yao XQ, Lau CW, et al. Vasorelaxant and antiproliferative effects of berberine.
- Zhao HP, Hong Y, Xie JD, et al. Effect of berberine on left ventricular remodeling in renovascular hypertensive rats [in Chinese].
- Wang J, Guo T, Peng QS, et al. Berberine via suppression of transient receptor potential vanilloid 4 channel improves vascular stiffness in mice.
- Lee YS, Kim WS, Kim KH, et al. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states.
- Kim SH, Shin EJ, Kim ED, et al. Berberine activates GLUT1-mediated glucose uptake in 3T3-L1 adipocytes.
- Turner N, Li JY, Gosby A, et al. Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action.
- Yin J, Gao Z, Liu D, et al. Berberine improves glucose metabolism through induction of glycolysis.
- Kong WJ, Zhang H, Song DQ, et al. Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression.
- Zhang Y, Li X, Zou D, et al. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine.
- Zhang H, Wei J, Xue R, et al. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression.
- Liu Y, Lou SY, He YM. Effects of berberine on cell proliferation, peroxisome proliferation activated receptor gamma, CAAT/enhancer binding protein mRNA and protein expression in 3T3-L1 pre-adipocytes [in Chinese].
- Zhou JY, Zhou SW, Zhang KB, et al. Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats.
- Huang C, Zhang Y, Gong Z, et al. Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARgamma pathway.
- Kong W, Wei J, Abidi P, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins.
- Li H, Chen W, Zhou Y, et al. Identification of mRNA binding proteins that regulate the stability of LDL receptor mRNA through AU-rich elements.
- Wang Y, Yi X, Ghanam K, et al. Berberine decreases cholesterol levels in rats through multiple mechanisms, including inhibition of cholesterol absorption.
- Li XY, Zhao ZX, Huang M, et al. Effect of berberine on promoting the excretion of cholesterol in high-fat diet-induced hyperlipidemic hamsters.
- Wang Y, Jia X, Ghanam K, et al. Berberine and plant stanols synergistically inhibit cholesterol absorption in hamsters.
- Cicero AF, Rovati LC, Setnikar I. Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol-lowering agents: a single-blind clinical investigation.
- Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.
- Zeng XH, Zeng XJ, Li YY. Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
- Marin-Neto JA, Maciel BC, Secches AL, et al. Cardiovascular effects of berberine in patients with severe congestive heart failure.
- Hong Y, Hui SS, Chan BT, Hou J. Effect of berberine on regression of pressure- overload induces cardiac hypertrophy in rats.
- Huang WM, Yan H, Jin JM, et al. Beneficial effects of berberine on hemodynamics during acute ischemic left ventricular failure in dogs.
- Imanshahidi M, Hosseinzadeh H. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine.
- Chan E. Displacement of bilirubin from albumin by berberine.
- Tan YZ, Wu AC, Tan BY, et al. Study on the interactions of berberine displace other drug from their plasma proteins binding sites.
- Wang YS.
- Zilaee M, Kermany T, Tavalaee S, et al. Barberry treatment reduces serum anti-heat shock protein 27 and 60 antibody titers and high- sensitivity C-reactive protein in patients with metabolic syndrome: a double blind, randomized, placebo controlled trial.
- Yarnell E. Recent clinical advances with berberine.